GreenRoot Labs Boswellia Joint pain Swelling Osteoarthritis
GreenRoot Labs Boswellia Joint pain Swelling Osteoarthritis, NPN 80146537: natural health product licensed in Canada. Medicinal ingredients: Boswellia serrata.
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Boswellia serrata Source : Boswellia serrata - Oléo-gomme-résine (écorce de tige) Extract : Matériel brut sec Extraction ratio : 36.036:1 Dry plant equivalent : 12,000 mg Potency : 40 % Boswellic acids | 333 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, farine de riz, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Helps relieve joint pain and swelling associated with osteoarthritis of the knee.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Known Adverse Reactions
Stop use if hypersensitivity/allergy occurs. When using this product you may experience gastrointestinal discomfort/disturbances.
- Cautions and Warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding. Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
Product record
- Other names
- Puroleo Boswellia Joint pain Swelling Osteoarthritis
- Licence holder
- Pureoyl Healthcare
- NPN or DIN-HM
- 80146537
- Status
- Active licence
- Licence date
- 30 December 2025
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
Source
Official Health Canada record, licence 80146537
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “GreenRoot Labs Boswellia Joint pain Swelling Osteoarthritis (Pureoyl Healthcare): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80146537-greenroot-labs-boswellia-joint-pain-swelling-osteoarthritis, updated 30 December 2025.